| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819623 | Journal of Cystic Fibrosis | 2018 | 7 Pages |
Abstract
These in vivo results, consistent with prior in vitro findings, indicate that the drug treatments restore near-normal function to S945L-CFTR, and support the use of ivacaftor as a treatment for CF patients who carry this allele.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Jeeyeon Kim, Zoe Davies, Colleen Dunn, Jeffrey J. Wine, Carlos Milla,